BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29250189)

  • 1. DDR2 facilitates papillary thyroid carcinoma epithelial mesenchymal transition by activating ERK2/Snail1 pathway.
    Liang Z; Xie WJ; Zhao M; Cheng GP; Wu MJ
    Oncol Lett; 2017 Dec; 14(6):8114-8121. PubMed ID: 29250189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1.
    Xie B; Lin W; Ye J; Wang X; Zhang B; Xiong S; Li H; Tan G
    J Exp Clin Cancer Res; 2015 Sep; 34(1):101. PubMed ID: 26362312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis.
    Zhang K; Corsa CA; Ponik SM; Prior JL; Piwnica-Worms D; Eliceiri KW; Keely PJ; Longmore GD
    Nat Cell Biol; 2013 Jun; 15(6):677-87. PubMed ID: 23644467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.
    Wang YG; Xu L; Jia RR; Wu Q; Wang T; Wei J; Ma JL; Shi M; Li ZS
    Dig Dis Sci; 2016 Aug; 61(8):2272-2283. PubMed ID: 27010547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial-mesenchymal transition programme under hypoxia.
    Ren T; Zhang W; Liu X; Zhao H; Zhang J; Zhang J; Li X; Zhang Y; Bu X; Shi M; Yao L; Su J
    J Pathol; 2014 Dec; 234(4):526-37. PubMed ID: 25130389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
    Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
    Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated CXCL5-CXCR2 axis promotes the migration, invasion and EMT of papillary thyroid carcinoma cells via modulation of β-catenin pathway.
    Cui D; Zhao Y; Xu J
    Biochimie; 2018 May; 148():1-11. PubMed ID: 29471001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between activated STAT3 protein and epithelial-mesenchymal transition in papillary thyroid carcinoma].
    Zhang Z; Bai Y; Li P; Zhao J; Wang Y; Sun L; Tang J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 27(22):1265-8. PubMed ID: 24616987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CXCL12-CXCR4 axis promotes migration, invasiveness, and EMT in human papillary thyroid carcinoma B-CPAP cells via NF-κB signaling.
    Lin Y; Ma Q; Li L; Wang H
    Biochem Cell Biol; 2018 Oct; 96(5):619-626. PubMed ID: 29316404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. lncRNA BANCR promotes EMT in PTC via the Raf/MEK/ERK signaling pathway.
    Wang Y; Gu J; Lin X; Yan W; Yang W; Wu G
    Oncol Lett; 2018 Apr; 15(4):5865-5870. PubMed ID: 29552216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Special issue "The advance of solid tumor research in China": Discoidin domain receptor 2 promotes colorectal cancer metastasis by regulating epithelial mesenchymal transition via activating AKT signaling.
    Xu X; Duan X; Wang S; Zhang Y; Gao Y; Xu X; Yeerkenbieke G; Zhou J; Li J
    Int J Cancer; 2023 Jan; 152(1):51-65. PubMed ID: 35904852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis.
    Grither WR; Divine LM; Meller EH; Wilke DJ; Desai RA; Loza AJ; Zhao P; Lohrey A; Longmore GD; Fuh KC
    Oncogene; 2018 Mar; 37(13):1714-1729. PubMed ID: 29348456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twist1 regulates the epithelial-mesenchymal transition via the NF-κB pathway in papillary thyroid carcinoma.
    Lv N; Shan Z; Gao Y; Guan H; Fan C; Wang H; Teng W
    Endocrine; 2016 Mar; 51(3):469-77. PubMed ID: 26289126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deltex3 inhibits Epithelial Mesenchymal Transition in Papillary Thyroid Carcinoma via promoting ubiquitination of XRCC5 to regulate the AKT signal pathway.
    Wang L; Huang Y; Liu C; Guo M; Ma Z; He J; Wang A; Sun X; Liu Z
    J Cancer; 2021; 12(3):860-873. PubMed ID: 33403043
    [No Abstract]   [Full Text] [Related]  

  • 15. BIRC7 promotes epithelial-mesenchymal transition and metastasis in papillary thyroid carcinoma through restraining autophagy.
    Liu K; Yu Q; Li H; Xie C; Wu Y; Ma D; Sheng P; Dai W; Jiang H
    Am J Cancer Res; 2020; 10(1):78-94. PubMed ID: 32064154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma.
    Wang Z; Zhang H; Zhang P; Dong W; He L
    Tumour Biol; 2016 Jun; 37(6):7633-44. PubMed ID: 26687649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant Expression of Androgen Receptor Associated with High Cancer Risk and Extrathyroidal Extension in Papillary Thyroid Carcinoma.
    Chou CK; Chi SY; Chou FF; Huang SC; Wang JH; Chen CC; Kang HY
    Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32365531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y; Wang J; Han J; Luo D; Sun Z
    Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TFF3 Contributes to Epithelial-Mesenchymal Transition (EMT) in Papillary Thyroid Carcinoma Cells via the MAPK/ERK Signaling Pathway.
    Lin X; Zhang H; Dai J; Zhang W; Zhang J; Xue G; Wu J
    J Cancer; 2018; 9(23):4430-4439. PubMed ID: 30519349
    [No Abstract]   [Full Text] [Related]  

  • 20. FKBP51 promotes migration and invasion of papillary thyroid carcinoma through NF-κB-dependent epithelial-to-mesenchymal transition.
    Gao Y; Elamin E; Zhou R; Yan H; Liu S; Hu S; Dong J; Wei M; Sun L; Zhao Y
    Oncol Lett; 2018 Dec; 16(6):7020-7028. PubMed ID: 30546435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.